• Subscribe
  • Newsfeed
  • About
  • Jobs
Announce News

Monograph Capital

To add a bio or update investment portfolio, please click update information.

Investment Portfolio

    Elevara raises £50m Series A led by Forbion and Sofinnova Partners to develop therapies for rheumatoid arthritisElevara raises £50m Series A led by Forbion and Sofinnova Partners to develop therapies for rheumatoid arthritis
    Elevara Medicines
    22 Oct 2025

    Elevara raises £50m Series A led by Forbion and Sofinnova Partners to develop therapies for rheumatoid arthritis

    Elevara develops oral therapies for rheumatoid arthritis by targeting synovial fibroblasts rather than the immune system, aiming to improve remission rates in chronic inflammatory disease.

Monograph Capital
    • Life Sciences
  • 1(12 months)
  • monograph.bio
  • Update Information

More venture news

  • Combat Medical raises a £2.6m Series A led by T&J Meyer Family Foundation for hard-to-treat bladder cancer
    Combat Medical
    12 Mar 2026

    Combat Medical raises a £2.6m Series A led by T&J Meyer Family Foundation for hard-to-treat bladder cancer

    Series AHealth
  • Outpost unlocks £13m Series A led by Ribbit for cross-border payments and tax compliance infrastructure
    Outpost
    10 Mar 2026

    Outpost unlocks £13m Series A led by Ribbit for cross-border payments and tax compliance infrastructure

    Series AFintech
  • Shellworks raises £11m Series A led by Alter Equity for biodegradable packaging made from microbial fermentation
    Shellworks
    4 Mar 2026

    Shellworks raises £11m Series A led by Alter Equity for biodegradable packaging made from microbial fermentation

    Series ASupply Chain

Sign-up to our newsletter

The UK Weekly email covers every VC round from last week, firms that are hiring, and much more

Soapbox Ventures Limited © 2026

Disclaimer

Privacy Policy

LinkedIn

Announce

  • Share your story

General

  • Read the latest
  • About Soapbox

Information not up to date?

Get in touch

Soapbox Ventures Limited © 2026

Disclaimer

Privacy Policy

LinkedIn